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Policy Points:
 An estimated 700,000 people in the United States have “long COVID,”
that is, symptoms of COVID-19 persisting beyond three weeks.
 COVID-19 and its long-term sequelae are strongly influenced by so-
cial determinants such as poverty and by structural inequalities such as
racism and discrimination.
 Primary care providers are in a unique position to provide and coordinate
care for vulnerable patients with long COVID.
 Policy measures should include strengthening primary care, optimizing
data quality, and addressing the multiple nested domains of inequity.
The pandemic has highlighted and exacerbated healthinequities in both acute coronavirus disease 2019 (COVID-19)and its longer-term sequelae.1–4 Symptoms of COVID-19 per-
sist in approximately one in 10 patients.5 Acute symptoms include
shortness of breath, cough, myalgias, disturbances in the sense of taste
and smell, fatigue, fever, chills, and, less commonly, rhinitis and gas-
trointestinal symptoms. By contrast, the term “long COVID,” coined
by patients, refers to both postacute symptoms (lasting more than
three weeks) and chronic symptoms (lasting more than 12 weeks).6
Long COVID is a multisystem disease of unknown cause whose
manifestations, while partially overlapping the acute presentation,
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vary widely among patients and are exacerbated by comorbidities
and vulnerabilities (Box 1). It occurs in adults who were hospital-
ized and those who were not6–8 and (more rarely) in children.9 At
the time of this writing, the United States had more than 17 million
diagnosed cases of COVID-19,10,11 which translates into approximately
1,700,000 people with long COVID. This does not include the likely
underreporting of COVID-19 cases, the proportion of which in one
study ranged from one in three to one in 406.12 The implications for
health services are substantial. Given the heterogeneity in definitions
of long COVID and the lack of centralized registries of patients with
the disease, those who might suffer from long-term symptoms might
mistakenly be recorded as recovered.
The natural history of long COVID appears to be gradual improve-
ment over time in most cases, though recovery is typically measured
in months.6,8 Some patients require comprehensive assessment to ex-
clude serious complications that might underlie their symptoms (no-
tably, thrombo-embolic disease of the lungs, heart, and brain), along
with holistic clinical intervention and follow-up. Patients without con-
cerning symptoms should be supported but spared overinvestigation and
overmedicalization.6,16,17 Those who have survived admission to an in-
tensive care unit and those with preexisting respiratory, cardiovascular,
or cerebrovascular disease are likely to require more specialized and pro-
longed rehabilitation.16,18,19 Given the paucity of evidence, it is cur-
rently unclear which of these issues related to long COVID are directly
related to or caused by the disease itself and which are unrelated but may
be made more difficult to treat owing to COVID-19 and its after-effects.
Acute COVID-19 is associated with significant racial disparities.20–23
Black, Latinx, American Indian, Alaska Native, Asian, Native Hawaiian
and Pacific Islander, and other non-white racial groups in the United
States are less likely to have access to testing;24,25 more likely to be
infected;25–28 more likely to be hospitalized overall,29 though less likely
to be hospitalized for any given level of severity,21 and more likely to
have an adverse clinical outcome (including death).21,27,30,31 In addi-
tion, these racial groups are overrepresented in high-risk occupations,
including those with a higher risk of mortality from COVID-19 (e.g.,
health and care workers, hospital porters and cleaners, bus drivers, trans-
port workers),32 are less likely to have adequate health insurance,33
and are less likely to receive compassionate end-of-life care.34 They are
also more likely to be severely affected economically with job losses or
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Box 1. Some of the Many Manifestations of Long COVID6,13–15
The Lived Experience




 Nonspecific chest pains (“lung burn”)
 Palpitations or dizziness




 Skin lesions, especially chilblain-like on the extremities (“COVID toe”)
 Mood swings
Clinical Examination and Tests
May identify signs of past infection, active inflammatory disease or systemic
complications, including
 Fever
 Positive antibody tests for COVID-19 (but absence of evidence of
infection does not exclude long COVID)
 Abnormal blood panel (e.g., white cell count, C-reactive protein, brain
natriuretic peptide, troponin, D-dimer)
 Thrombo-embolism (coronary, pulmonary, cerebral)
 Cardiac disease: myocarditis, pericarditis, dysrhythmias, heart failure
 Respiratory disease: pneumonitis, pleural effusion
 Neurological disease: stroke, seizures, encephalitis, cranial neuropathies
 Psychiatric conditions: posttraumatic stress disorder, depression, anxiety
Comorbidities and Other Relevant Concerns
Note: not all new symptoms in a patient after COVID-19 are due to long COVID
 Long-term conditions (e.g., diabetes, heart failure, hypertension, asthma,
epilepsy)
 New conditions unrelated to COVID-19 (e.g., infection, suspected
neoplasm)
 General health and well-being including sleep status, nutritional status,
sarcopenia, tissue viability
 Family circumstances (e.g., bereavement, unemployment, domestic
conflict)
 Community resilience (e.g., loss of community resources or leaders,
lockdown-related restrictions)
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lack of access to welfare.35,36 While they are also more likely to have
comorbidities and poor prognostic features (e.g., obesity),4,37 control-
ling for such factors reduces the differences in COVID-19 mortality
among ethnic groups and, in some cases, eradicates them altogether,20,38
prompting calls to go beyond “biological” explanations.3,39 Later
we discuss structural explanations for racial disparities in the on-
set and outcome of acute COVID-19, summarized schematically in
Figure 1.2–4,20,40–42
Whereas the association between race/ethnicity and health inequity in
acute COVID-19 is now well established, the association of inequities
with long COVID is relatively unexplored.4,22,43 To improve the care of
vulnerable populations with long COVID, we need to (1) understand,
acknowledge, and engage with the densely woven patterns of disad-
vantage that encumber those with postacute and chronic illness;44 (2)
strengthen existing services, especially in ambulatory primary care; (3)
optimize data quality and use those data strategically for planning and
monitoring; and (4) provide access to resources in acknowledgement of
the multiple nested domains of inequity operating at global, national,
community, and individual scales. We will consider these approaches in
turn.
Understanding the Multiple Barriers to
Health Equity in Long COVID
Vulnerable groups encounter a range of barriers to health care linked
to such social determinants as gender, race/ethnicity, education, occu-
pation, and transport.45,46 Next we consider those barriers that may be
particularly relevant to long COVID.
Economic Barriers
Long COVID has a negative economic impact in at least two ways. The
first is medical expenses.47 A single acute COVID-19 case without hos-
pitalization has a direct medical median cost of $3,045: if health care is
sought after infection (e.g., outpatient visits), then the cost increases
to $3,994.48 In case of hospitalization, the median cost is $14,366
and rises to $18,579.48 These figures are the direct cost to the payer.
Out-of-pocket costs include multiple other domains not directly
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connected to medical services, since, like any multisystem illness,
COVID-19 can affect many areas of life. Although postacute and chronic
stage economic data are not available, we can infer that the follow-up and
treatment of themultisystemic symptoms will vastly increase health care
costs, particularly for some patients. For many patients, this cost would
be a deterrent from screening or, for those without health insurance cov-
erage, seeking advanced care.
Postacute care ranges from skilled nursing facilities to inpatient re-
habilitation to home health agencies.14 In the United States, the cost of
skilled nursing facilities is an average of $6,844 per month for a semipri-
vate room to $7,698 for a private room. A health care aide costs an av-
erage of $20.50 per hour, a rate that may increase in the evenings, on
weekends, and on public holidays.49
Vulnerable populations facing postacute and chronic COVID-19 may
have little or no health insurance coverage.47,50,51 Black and Latinx peo-
ple tend to be uninsured at higher rates than white people are, par-
ticularly in states that did not expand Medicaid under the Afford-
able Care Act (ACA). As noted earlier, this affects the costs of testing
and the resultant willingness to be tested. The Families First Coron-
avirus Response Act (FFCRA) requires “certain plans to cover speci-
fied COVID-19 testing services without cost sharing … however there
is no federal requirement specifically mandating private health insur-
ance coverage of items or services related to COVID-19 treatment.”52
The coverage of Medicaid and the Children’s Health Insurance Pro-
gram (CHIP) testing and diagnostic services varies by state, and most
out-of-pocket costs are capped at 5% of family income.53 Even though
Medicare beneficiaries do not pay the out-of-pocket cost of COVID-
19 testing and telehealth is temporarily covered, they will pay de-
ductibles, copays, or coinsurance in the case of hospitalization.53 Unin-
sured individuals—around 28million nonelderly people, many of whom
have jobs with a high exposure to COVID-19—must pay the full
cost.50,51
The second economic barrier is that debilitating and disabling symp-
toms interfere with people’s ability to work and hence to generate in-
come for themselves and their dependents. The vulnerable in society
have less job security, less flexibility in their roles, and less entitlement
to sick pay and occupational health services.54
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Geographical Barriers
People living in medically underserved areas, who include dispropor-
tionate numbers of Black and minority ethnic groups, may have inade-
quate access to primary care.55,56 Yet vulnerable groups also have more
comorbidities and hence a greater need for care.57 Poor public trans-
portation may delay vulnerable groups’ access to health care even in
areas not formally designated as medically underserved.58 The Amer-
ican Society of Civil Engineers recognizes that “despite increasing de-
mand, the nation’s transit systems have been chronically underfunded
[and] many Americans still have inadequate access to public transit.”59
The COVID-19 pandemic exacerbated the underprovision of transport
owing to safety concerns.60,61 This lack of reliable transportation is a bar-
rier in accessing health care, even though the use of public transportation
(more common among racial and ethnic minorities) is a known risk fac-
tor for COVID-19 infections.62,63
Housing and Segregation
Vulnerable populations tend to live in high-density areas and crowded
residences,64 which are associated with an increased risk of COVID-
19 infection. Residential segregation underlies and exacerbates health
disparities.65,66 For example, worse outcomes in tuberculosis have been
noted in communities where Black and Latinx individuals are predom-
inant, reflecting such segregation,67 and COVID-19 is expected to be-
have similarly.40,68
Occupational Barriers
Vulnerable groups are disproportionately represented among essential
workers (e.g., bus drivers, certified nursing assistants).68 Such workers
are often overlooked, undervalued, and stigmatized, and they are cur-
rently facing higher physical and mental health risks without the fi-
nancial means to opt out of their work.54,69,70 In addition to being at a
greater risk of acute COVID-19 by not having adequate personal pro-
tective equipment (PPE) and less ability to physically distance,54,71 es-
sential workers now also face a disproportionate burden of long COVID.
Other occupational groups that are likely to have high levels of
long COVID include those whose environmental conditions place them
at a high risk of acute COVID-19. For example, employees at meat
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processing plants work in close proximity with one another and in cold,
wet and noisy environments, leading in some cases to “superspreader”
events.70 Symptomatic or exposed employees often are ineligible for the
sick leave and health insurance that might allow them to remain at
home.49
Workers in these occupations typically lack the flexibility to deal with
the protracted or relapsing-remitting nature of long COVID symptoms,
together with the pandemic’s continuing implications (e.g., no child care
when schools close).72 In some cases, these workers face a moral trade-
off between protecting their own health and ensuring a basic family
income.
The Case for Strengthening Primary
Care Services
Barbara Starfield’s seminal research, published in this journal, showed
that traditional primary care—first contact, holistic, person-focused,
comprehensive, continuous and coordinated—saves lives, reduces suffer-
ing, and lowers overall health care costs.73 A review in theBritishMedical
Journal argued that these very characteristics, which enable continuity of
care, a respectful therapeutic relationship, and support as patients pace
themselves carefully toward recovery, make primary care an ideal setting
for managing many (though not all) cases of long COVID.6
The effective management of long COVID requires, first and fore-
most, recognition of the condition and empathic validation of the pa-
tient’s experience. It also requires a skilled, generalist assessment of
the multisystem disorder (which may affect virtually every organ in
the body) and judicious referral to cardiology, respiratory, neurological,
mental health, or other specialist colleagues as appropriate.6 A primary
care clinician who knows the patient and his or her life circumstances is
in an optimal position to coordinate and personalize the recovery plan
and understand the barriers the patient faces while struggling to follow
it. A comprehensive training program for generalist clinicians, along
with care pathways, guidance, and criteria to which patients should be
referred, must underpin a primary care–led long COVID response. A
diversified health care workforce, greater cultural humility, and fewer
health inequities are part and parcel of this effort, considering the role
of racial injustice in long COVID.33,74
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Even before the COVID-19 pandemic, vulnerable populations in
the United States faced inequitable access to primary ambulatory care
and quality health insurance.55,75,76 Accordingly, health care providers
should expect these challenges to be even greater with the burden of
chronic disease related to COVID-19. Given the large numbers involved,
primary care is likely to lack the capacity to provide ongoing, holistic,
and equitable care to all who need it. The “COVIDization” of health ser-
vices (i.e., a reorientation of clinicians and servicemodels to deal with the
pandemic’s immediate impact) has led to fewer emergency department
visits for heart attack, stroke, and uncontrolled diabetes;77 avoidance of
routine medical care;78 and (in European studies) delays in referrals for
suspected cancer.79,80
It is important to note that long COVID, particularly in vulnera-
ble groups, may be complicated by long-term conditions, notably dia-
betes, hypertension, ischemic heart disease, and chronic mental health
conditions.26,71,81 Hence, there is an argument for resourcing whole-
patient primary care support rather than (or in addition to) provid-
ing ring-fenced funding solely for long COVID. The early stages of
the COVID-19 pandemic highlighted issues with the resource alloca-
tion framework that discriminated against age, disability status, and
racial/ethnic disparities.82,83 This raised the ethical question of how
best, in a resource-limited setting, to allocate resources to support pa-
tients with long COVID without hurting those suffering from other
chronic conditions, especially since both COVID-19 and noncommu-
nicable diseases are clustered in minority groups. The World Health
Organization’s ethical values for a fair process in allocating resources—
transparency, inclusiveness, consistency, and accountability—may help
guide difficult decisions in which resources are limited.84 Also rel-
evant are wider political-economic questions, including the democ-
ratization of systems that concentrate wealth and disempower the
poor.
The Importance of High-Quality Data
and a Learning Health System
The long-term prognosis of long COVID is unknown. Not only do we
not know whether or how much a damaged myocardium, lung, or brain
may recover, we also do not know to what extent the ethnic and racial
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inequalities observed in acute COVID-19 will be mirrored—or even
exacerbated—as the disease becomes chronic. Unless we systematically
measure inequalities by race and ethnicity, they will remain invisible,
and poor outcomes in some groups will be attributed to biology rather
than to the structural determinants discussed earlier, such as poverty,
overcrowding, geographical underprovision, barriers to access, and sys-
temic racism more broadly.23,85
The collection of comprehensive, public, transparent, patient-
centered, and multidomain clinical and epidemiological data should be
(but appears not to be) an urgent national priority in the United States.
Indeed, the COVID Tracking Project claims that because of the lack
of official source-providing data, it is collecting the most complete data
available, including filing and partnering with Boston University’s Cen-
ter for Antiracist Research to track racial and ethnic data reported by
states.86
Primary health care could complement such initiatives by adopting
the principles of learning health systems and integrating data collec-
tion, analysis, and actionability through clinical practice.87,88 Such an
approach would require investment and coordination to ensure rigorous
and consistent coding, data quality assurance, information governance,
and effective and timely feedback into clinical practice.89 As an editorial
in the Lancet argued, “Detailed data on COVID-19 by age, sex, or ethnic-
ity/race are scant but should be available routinely and automatically.”20
In other words, a partnership between medicine and public health is
warranted.
The collection of consistently coded data sets from individ-
ual patient’s primary care records regarding postacute and chronic
COVID-19 would help support much-needed research on this new
condition.
Although some health care systems in the United States had begun
to collect data on social determinants of health before the onset of the
pandemic,90,91 collecting such data may or may not influence the in-
equities that affect communities. Primary care providers are in a unique
position to link the collection of social determinant data with intersec-
toral action with governments and institutions to redistribute resources
in a way that addresses these determinants and averts the inequitable
impact of long COVID on patients and communities.
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Addressing the Social Determinants of
Health in the United States
The United States is notorious worldwide for its high-cost and
profit-oriented health care system, which is also marked by striking
inequalities.92 Millions of Americans are facing prohibitive medical ex-
penses while being underinsured, uninsured, or unemployed.32,93 Fur-
thermore, those who are—directly or indirectly—newly unemployed as
a result of COVID-19 and its sequelae are often also newly uninsured.76
As King commented recently, “The patchwork way we govern and pay
for health care is unraveling in this time of crisis.”94 It is time to demand
reform.
Outside the United States, the goal of universal health care is widely
accepted as a means of achieving social justice and reducing health care
disparities, and a strong primary health care system is viewed as the
cornerstone of such a system.95,96 Universal health care would address
the current insurance coverage disparities faced by racial and ethnic mi-
norities, who are more likely to face unemployment and underinsurance
due to the pandemic.94,97 Despite the potential that universal health
care—whether through a socialized single-payer system as in the United
Kingdom, social insurance as in Germany, or a mixed public and private
model as in the Netherlands98—offers to mitigate economic and acces-
sibility barriers to health care,98 it is currently contested in the United
States.99
In the more immediate future, there is a strong argument for expand-
ing Medicaid coverage for vulnerable people with long COVID, as was
done for the acute phase of the pandemic.52,53,76 Medicaid allows low-
income persons to access COVID-related care after being infected. Medi-
caid can also function as a safety net for those becoming unemployed and
uninsured, but this would require public support and the political will
to increase federal funding to states and to make policies more consistent
in time of widespread job loss.100 Such an approach would acknowledge
that this disease (1) is a unique and devastating event not just for indi-
viduals but also for families and communities; (2) affects the vulnerable
disproportionately; and (3) has long-term physical, social, and economic
effects that could be partly mitigated by the provision of medical care
and support. As professionals who are closely embedded in their local
communities and who specialize in managing illness in a family and
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social context, primary care clinicians should organize and advocate as a
group for health equity in the vulnerable population who now suffer—
and will suffer—from long COVID.
More broadly, primary care clinicians should take a collective stance
against income inequality, racism, and discrimination. Being discrim-
inated against and economically disadvantaged leads both directly and
indirectly to physical and mental changes that increase a person’s vul-
nerability to disease.101 Without tackling the root causes of inequity,
neither COVID-19 itself nor its long-term effects can begin to be
addressed.3,45,85
The Need for Multilevel, International
Action on Social Determinants
A report from the World Health Organization in Health Organization
in 2010 provides a useful framework for informing policy intervention
to address the impacts of the pandemic (Figure 2).102 It recommends ad-
dressing multiple intersecting and nested domains in strategies oriented
to reducing or mitigating the social determinants of health.
As explained earlier, government should address inequalities at both
the individual and community levels that are linked to work, housing,
and transportation, as well as education and food supply. Data from pri-
mary care providers in a learning health system can help inform and
monitor specific policy interventions at these levels. But such data could
also contribute more indirectly to advocacy and action for solutions at
national and international levels.
The global, ecologic environment, for example, in addition to ex-
plaining the origins of the pandemic via animal-human spread, creates
the inhumane and unsafe conditions in which many people, especially
low-status essential workers, live and work. For another example, the
recurrent “superspreader” outbreaks of COVID-19 in US meat-packing
plants103 cannot be fully addressed without considering the meat
supply’s business drivers and corporate culture. In recent years, this
sector has seen extensive consolidation (small plants closing and being
replaced by very large plants) and vertical integration (a single firm
controlling the entire supply chain from the farm to the supermarket).
These businesses are now typically owned by vast international compa-
nies employing thousands of workers to achieve economies of scale.104
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Corporate social responsibility has been limited, with a progressive ero-
sion of workers’ rights to sick leave and other benefits.105 Since a high
proportion of workers in the meat business are migrants, we also need to
take account of international labor standards as well as domestic laws.106
Conclusion
In the United States, COVID-19 is shifting from an acute national dis-
aster to a chronic policy crisis, made no easier by the recent political con-
text. The overall problem is bigger than any of us, individually or even
collectively, can solve. There are, however, specific measures that we can
take to reduce the impact of long COVID on vulnerable groups. First,
primary care providers need to understand, recognize, and engage with
both the clinical and the wider aspects of this new condition, involv-
ing a renewed, broader collaboration with public health. Second, health
services must be strengthened to a level proportionate to the rapidly
growing need, including extending capacity and developing new train-
ing programs, care pathways, and guidance for primary care clinicians.
Third, high-quality data sets should be collaboratively and systemati-
cally collected and used in real time to improve system learning and
bolster the public health response. Fourth, attention should be paid to
providing access to resources to combat problems, such as equitable ac-
cess to and distribution of health care, in global, national, community,
and individual settings. Fifth, with a view to the longer term, profession-
als should advocate collectively for the health care reform that is long
overdue in this country. Finally, advocacy and data from primary care
should be used to contribute to collaborative efforts to address transna-
tional grand challenges such as the links between corporate interests,
worker exploitation, and COVID-19.
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